Skip to Main Content


Metabolic liver disease has traditionally referred to diseases that result from inborn errors of metabolism. These disorders are due to a single enzyme defect that affects the synthesis or catabolism of a carbohydrate (CHO), protein, or lipid. These defects in metabolism can result in either liver failure or cirrhosis, with or without injury to other tissues, or relative sparing of the liver with primary toxicity to other organ systems (Table 28–1). Metabolic disorders that arise in the liver with primary toxicity to other organ systems are not addressed in this chapter. This chapter approaches metabolic-induced liver disease not only from the traditional approach, those resulting from a single enzyme defect, but also as a genetic susceptibility induced by a trigger, such as a drug or a metabolic derangement associated with visceral obesity (nonalcoholic fatty liver disease (NAFLD)).

Table Graphic Jump Location
Table 28–1. Inborn Errors of Metabolism Causing Liver Disease

Taken individually, single enzyme defects are rare, although as a group they constitute at least 10% of pediatric liver transplantations. Wilson’s disease, alpha-1-antitrypsin deficiency (A1AT), and cystic fibrosis are the most common inherited metabolic conditions that affect the liver and are discussed individually in this textbook. Fortunately, in children most drug-induced liver disease (DILI) remains uncommon, although certain pediatric patient populations are at increased risk. NAFLD is becoming a worldwide problem of childhood and is the most common cause of liver disease in this age group. The increase in prevalence parallels the epidemic of obesity.1 This chapter will address the following three categories of metabolic liver disease in separate sections: inherited metabolic-induced liver disease, DILI, and obesity-induced NAFLD.




Enzymatic disorders that cause liver disease include disorders of CHO, protein, lipid/microsomal, and bile acid synthesis. Because the pathogenesis of these disorders is directly related to the metabolic pathway where the defect occurs, each class of disorders is addressed separately.


Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.


About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessPediatrics Full Site: One-Year Subscription

Connect to the full suite of AccessPediatrics content and resources including 20+ textbooks such as Rudolph’s Pediatrics and The Pediatric Practice series, high-quality procedural videos, images, and animations, interactive board review, an integrated pediatric drug database, and more.

$595 USD
Buy Now

Pay Per View: Timed Access to all of AccessPediatrics

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.